ESC 365 - Treatment with S1P modulators initiated 24 hours post-ischemia/reperfusion yields optimal outcomes

ESC Professional Premium Access

Treatment with S1P modulators initiated 24 hours post-ischemia/reperfusion yields optimal outcomes

Session: Molecular pathways of injury and repair in ischaemic cardiomyopathy

Topic: Ischaemia, Infarction, Cardioprotection

Speaker: Ms J. Seel (Dusseldorf, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Ms Jasmin Seel

Dusseldorf (Germany)

0 follower

4 more presentations in this session

Differentiation between arginase 1 and 2 in regulating tolerance to cardiac ischemia-reperfusion via nitric oxide signaling by red blood cells

Speaker: Doctor J. Yang (Stockholm, SE)

LV-Arterial coupling is impaired by nicotine delivered either via E-cigarettes or standard cigarettes in rats with myocardial infarction

Speaker: Doctor R. Alavi (Pasadena, US)

Glycopolymer P-SF attenuates myocardial ischemia-reperfusion injury by modulating macrophage PANoptosis

Speaker: Mrs G. Yu (Shanghai, CN)

Targeting phospholipid metabolism in cardiac ischemia-reperfusion injury protection mediated by PITPNC1

Speaker: Doctor W. Zhu (Shanghai, CN)

Access the full session

Molecular pathways of injury and repair in ischaemic cardiomyopathy

Speakers: Ms J. Seel, Doctor J. Yang, Doctor R. Alavi, Mrs G. Yu, Doctor W. Zhu

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources